
-
What are regulatory T-cells? Nobel-winning science explained
-
Indirect talks on ending Gaza war begin in Sharm El-Sheikh: Egypt media
-
OpenAI signs multi-billion dollar chip deal with AMD
-
Salah under fire as Liverpool star loses his spark
-
Paris stocks drop as French PM resigns, Tokyo soars
-
ICC finds Sudan militia chief guilty of crimes against humanity
-
Zverev dumped out of Shanghai Masters by France's Rinderknech
-
One hiker dead, hundreds rescued after heavy snowfall in China
-
Hundreds stage fresh anti-government protests in Madagascar
-
Feminist icon Gisele Pelicot back in court as man appeals rape conviction
-
US government shutdown enters second week
-
Kasatkina ends WTA season early after hitting 'breaking point'
-
Paris stocks drop as French PM resigns
-
Death toll from Indonesia school collapse rises to 63
-
Medicine Nobel to trio who identified immune system's 'security guards'
-
UN rights council launches probe into violations in Afghanistan
-
UK author Jilly Cooper dies aged 88
-
Jilly Cooper: Britain's queen of the 'bonkbuster' novel
-
Streaming stars' Le Mans race scores Twitch viewer record
-
England rugby star Moody 'shocked' by motor neurone disease diagnosis
-
Leopard captured after wandering into Indonesian hotel
-
Israel, Hamas due in Egypt for ceasefire talks
-
Rescuers scramble to deliver aid after deadly Nepal, India floods
-
Tokyo stocks soar on Takaichi win, Paris sinks as French PM resigns
-
OpenAI offers more copyright control for Sora 2 videos
-
Australia prosecutors appeal 'inadequate' sentence for mushroom murderer: media
-
Rugby World Cup-winning England star Moody has motor neurone disease
-
Trump says White House to host UFC fight on his 80th birthday
-
Vast reserves, but little to drink: Tajikistan's water struggles
-
US government shutdown may last weeks, analysts warn
-
Arsenal host Lyon to start new Women's Champions League format
-
Gloves off, Red run, vested interests: Singapore GP talking points
-
Bills, Eagles lose unbeaten records in day of upsets
-
Muller on target as Vancouver thrash San Jose to go joint top
-
Tokyo soars, yen sinks after Takaichi win on mixed day for Asia
-
China's chip challenge: the race to match US tech
-
UN rights council to decide on creating Afghanistan probe
-
Indonesia sense World Cup chance as Asian qualifying reaches climax
-
ICC to give war crimes verdict on Sudan militia chief
-
Matthieu Blazy to step out as Coco's heir in Chanel debut
-
Only man to appeal in Gisele Pelicot case says not a 'rapist'
-
Appetite-regulating hormones in focus as first Nobel Prizes fall
-
Gisele Pelicot: French rape survivor and global icon
-
Negotiators due in Egypt for Gaza talks as Trump urges quick action
-
'My heart sank': Surging scams roil US job hunters
-
Competition heats up to challenge Nvidia's AI chip dominance
-
UK police to get greater powers to restrict demos
-
Valsoft Corporation Announces Creation of Operating Groups to Strengthen Portfolio Management and Long-Term Growth
-
Form Bio and Cure Rare Disease Partner to Accelerate Genetic Medicine Development, Advancing CRD's Duchenne Muscular Dystrophy Program
-
A $1 SIM Card Nearly Triggered America's Zero Day; Here's How SMX Could Stop the Next Attempt (NASDAQ: SMX)
RIO | 1.72% | 67.265 | $ | |
CMSC | -0.32% | 23.795 | $ | |
BTI | -0.41% | 51.03 | $ | |
SCS | -0.44% | 17.035 | $ | |
BCE | -0.73% | 23.19 | $ | |
NGG | 0% | 73.43 | $ | |
CMSD | -0.1% | 24.426 | $ | |
RBGPF | -2.92% | 76 | $ | |
BCC | -1.4% | 76.56 | $ | |
JRI | -0.48% | 14.231 | $ | |
GSK | 1.08% | 43.825 | $ | |
AZN | 0.84% | 86.03 | $ | |
RYCEF | -0.7% | 15.65 | $ | |
VOD | -0.68% | 11.283 | $ | |
RELX | 0.48% | 46.635 | $ | |
BP | 2.27% | 34.952 | $ |

Medical Care Technologies Inc. (OTC PINK:MDCE) Unveils Patent-Pending AI Mental Health Tracker Targeting $400 Billion Market
MESA, ARIZONA / ACCESS Newswire / September 2, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE), an innovator in AI-powered healthcare technologies, today announced its AI Mental Health Tracker, a breakthrough solution designed to transform how anxiety, depression, and PTSD are detected and monitored. Visit the official site for more details at https://medicalcaretechnologies.com.
The. patent pending proprietary platform will leverage high-frame-rate facial landmark tracking, temporal micro-expression analysis, and emotion-recognition neural networks to uncover subclinical signs of psychological distress often missed by traditional screenings. With the ability to operate seamlessly through smartphones and webcams, this tool provides scalable, cost-effective access to real-time mental health diagnostics worldwide.
The global mental health market is valued at more than $400 billion and is expected to accelerate due to increased demand for digital therapeutics. By providing a non-invasive, AI-driven screening tool, MDCE is positioned to capture significant market share across telehealth, education, military, and workplace wellness programs.
"Mental health remains one of the most underserved areas in global healthcare," said Marshall Perkins III. "Our AI solution has the potential to revolutionize early detection, improve access, and dramatically reduce risk."
MDCE plans to integrate the AI Mental Health Tracker into its multi-vertical health platform, with a beta app launch targeted for 2026.
Safe Harbor Statement:
This press release contains forward-looking statements within the meaning of federal securities laws. Actual results may differ materially due to risks and uncertainties, including market conditions, regulatory approvals, and product development timelines. Medical Care Technologies Inc. undertakes no obligation to update these statements except as required by law.
Contact:
Investor Relations
Medical Care Technologies Inc.
[email protected]
Website: www.mdcestock.com
SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)
View the original press release on ACCESS Newswire
P.Santos--AMWN